Western blot analysis, consistent with immunohistochemical data, showed a significant decrease in CD86 protein expression and an increase in CD206 protein expression in the hippocampi of anti-TNFSF10 treated 3xTg-AD mice. This evidence concerns the gene CD86 and Alzheimer disease.